Literature DB >> 708019

In vitro activity of thienamycin.

F P Tally, N V Jacobus, S L Gorbach.   

Abstract

The in vitro activity of thienamycin was tested against 135 aerobic and anaerobic bacteria. The compound was highly active against resistant gram-negative bacilli and penicillin-resistant Straphylococcus aureus. The antianaerobic spectrum of the drug seemed to be comparable to that of metronidazole.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708019      PMCID: PMC352476          DOI: 10.1128/AAC.14.3.436

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Susceptibility of anaerobes to cefoxitin and other cephalosporins.

Authors:  F P Tally; N V Jacobus; J G Bartlett; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

2.  Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.

Authors:  E C Ernst; S Berger; M Barza; N V Jacobus; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

3.  Bacteroides fragilis resistant to the administration of clindamycin.

Authors:  J S Salaki; R Black; F P Tally; J W Kislak
Journal:  Am J Med       Date:  1976-03       Impact factor: 4.965

Review 4.  Therapy for infections due to anaerobic bacteria: an overview.

Authors:  S M Finegold
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

5.  Susceptibility of anaerobic bacteria to 23 antimicrobial agents.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

6.  Binding of thienamycin and clavulanic acid to the penicillin-binding proteins of Escherichia coli K-12.

Authors:  B G Spratt; V Jobanputra; W Zimmermann
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

  6 in total
  34 in total

1.  Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity.

Authors:  S S Weaver; G P Bodey; B M LeBlanc
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

Review 2.  In vitro and pharmacokinetic properties of the carbapenems.

Authors:  R Wise
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

3.  Penem derivatives: beta-lactamase stability and affinity for penicillin-binding proteins in Escherichia coli.

Authors:  S Ohya; Y Utsui; S Sugawara; M Yamazaki
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

4.  N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria.

Authors:  D A Martin; C V Sanders; R L Marier
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

5.  Imipenem-cilastatin as initial therapy for febrile cancer patients.

Authors:  G P Bodey; M E Alvarez; P G Jones; K V Rolston; L Steelhammer; V Fainstein
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

6.  Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

Review 7.  The evolving role of chemical synthesis in antibacterial drug discovery.

Authors:  Peter M Wright; Ian B Seiple; Andrew G Myers
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-02       Impact factor: 15.336

8.  In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole.

Authors:  A Gutiérrez Altés; M Díez Enciso; P Peña García; A Campos Bueno
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

9.  Phagocytic function and antibody-dependent cellular cytotoxicity of human neutrophils in the presence of N-formimidoyl thienamycin.

Authors:  A B Rodriguez; C Barriga; M de la Fuente
Journal:  Agents Actions       Date:  1990-08

10.  In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.

Authors:  M Nasu; J P Maskell; R J Williams; J D Williams
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.